跳至主要内容
临床试验/CTRI/2019/01/017325
CTRI/2019/01/017325尚未招募2 期

Fluorescein guided surgery for resection of malignant glioma: A randomised control trial

Department of Neurosurgery0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • newly diagnosed, untreated suspected high grade glioma and who are eligible for surgery according to the study surgeon

排除标准

  • 1. tumours of the midline, basal ganglia, cerebellum, or brain stem as assessed by MRI
  • 2. more than one contrast-enhancing lesion
  • 3. substantial, non-contrast enhancing tumour areas suggesting low-grade glioma
  • with malignant trans formation
  • 4.medical reasons precluding MRI (eg, pacemaker, metallic implants)
  • 5. inability to give consent because of dysphasia or language barrier
  • 6.tumour location did not enable complete resection of
  • contrast-enhancing tumour as decided by individual
  • study surgeon;
  • 7. Karnofsky performance scale 60 or less;
  • 8. renal insufficiency
  • 9.hepatic insufficiency
  • 10.history of malignant tumours at any other body site

研究者

相似试验

se of fluorescein in brain tumor surgery | 临床试验